粪便钙卫蛋白和粪便吲哚可预测艰难梭菌反复感染患者粪便微生物群移植的结果。
Fecal calprotectin and fecal indole predict outcome of fecal microbiota transplantation in subjects with recurrent Clostridium difficile infection.
作者信息
Hibbard J, Jiang Z-D, DuPont H L
机构信息
Ohio Wesleyan University, USA.
Kelsey Research Foundation, USA; University of Texas School of Public Health, USA.
出版信息
Anaerobe. 2019 Apr;56:102-105. doi: 10.1016/j.anaerobe.2019.03.006. Epub 2019 Mar 6.
Fecal calprotectin and indole were studied in 134 subjects with recurrent CDI before and after FMT. Reduced fecal calprotectin (p = 0.0353, 95% CI 0.1305-0.1439) and rising levels of indole (p < 0.0001, 95% CI < 0.0001-0.0003) predicted successful treatment. A ratio of recal calprotectin/indole may provide prognostic value for FMT (p = 0.0004, 95% CI 0.22-0.87).
对134例复发性艰难梭菌感染（CDI）患者在粪菌移植（FMT）前后的粪便钙卫蛋白和吲哚进行了研究。粪便钙卫蛋白降低（p = 0.0353，95%置信区间0.1305 - 0.1439）和吲哚水平升高（p < 0.0001，95%置信区间< 0.0001 - 0.0003）预示着治疗成功。粪便钙卫蛋白/吲哚比值可能为粪菌移植提供预后价值（p = 0.0004，95%置信区间0.22 - 0.87）。
Zotero 插件